Skip to main content

Table 5 Type of treatment of all studied patients

From: Role of PET/CT in patients with unexplained rising alpha fetoprotein post HCC interventional management

Type of treatmentAll studied patients (n = 40)
No.%
RFA1025%
MWA512.5%
TACE1537.5%
Combined1025%